Table 1.
No chemotherapy | Chemotherapy | P-value | |
---|---|---|---|
n= 2147 (%) | n= 184 (%) | ||
Age, years | 58.4 ± 13.7 | 57.3 ± 10.6 | 0.30 |
Men | 1045 (49) | 104 (57) | 0.04 |
Race | 0.40 | ||
Indian/Alaskan | 9 (0.4) | 1 (0.5) | |
Asian | 89 (4) | 5 (3) | |
Black/Black Hispanic | 170 (8) | 10 (5) | |
Hispanic/Hispanic unknown | 73 (3) | 2 (1) | |
White | 1650 (77) | 156 (85) | |
Unknown | 156 (7) | 10 (5) | |
Current smoker | 328 (15) | 28 (15) | 0.98 |
>2 alcoholic drinks/day | 61 (3) | 6 (3) | 0.74 |
Body mass index, median | 26.9 | 27.2 | 0.15 |
ASA physical status classification | 0.72 | ||
1 | 35 (1.6) | 3 (1.6) | |
2 | 729 (34) | 58 (31.5) | |
3 | 1272 (59) | 117 (64) | |
4 | 110 (0.5) | 6 (3) | |
5 | 1 (0.04) | 0 (0) | |
Co-morbidities | |||
Diabetes mellitus | 0.07 | ||
No | 1825 (85) | 168 (91) | |
Oral hypoglycaemic treatment | 228 (11) | 11 (6) | |
Insulin therapy | 94 (4) | 5 (3) | |
History of severe chronic obstructive pulmonary disease | 67 (3) | 3 (2) | 0.26 |
Congestive heart failure within the 30 days prior to surgery | 8 (0.4) | 1 (0.5) | 0.72 |
Hypertension requiring medication | 988 (46) | 74 (40) | 0.13 |
Loss of >10% of body weight in previous 6 months | 114 (5) | 12 (6.5) | 0.49 |
Transfusion >5 units pRBC preoperatively | 6 (0.3) | 1 (0.5) | 0.44 |
Steroid use for chronic condition | 40 (2) | 4 (2) | 0.77 |
Ascites | 31 (1) | 2 (1) | 0.69 |
Disseminated cancer | 818 (38) | 147 (77) | <0.001 |
Radiotherapy for malignancy in last 90 days | 16 (0.7) | 11 (6) | <0.001 |
ASA, American Society of Anesthesiologists; pRBC, packed red blood cells
P-values shown in bold are significant at P < 0.05